The subsequent study by Li et al. showed that downregulation of NEDD4-1 in prostate and lung cancer cells could reduce cancer cell proliferation and inhibit autophagy, which was accompanied by a reduction in the formation of LC3-positive phagophores and a decreased conversion of LC3-I to LC3-II (Li et al. 2015). Here, MAP1LC3A is linked to cancer.